# MediciNova (MNOV) — Earnings

MNOV · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mnov/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.05 |
| EPS estimate | −$0.06 |
| EPS surprise | +21.01% |
| Revenue surprise | +512.00% |
| Revenue | $459,000.00 |
| Revenue estimate | $75,000.00 |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1226616/000119312526349323/mnov-20260630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | −$0.06 | −$0.05 | 21.01% | $75,000.00 | $459,000.00 |
| Q1 2026 | May 14, 2026 | −$0.08 | −$0.05 | 39.76% | — | $186,984.00 |
| Q4 2025 | Feb 20, 2026 | −$0.12 | −$0.06 | 50.00% | — | $151,000.00 |
| Q3 2025 | Nov 12, 2025 | −$0.12 | −$0.12 | 0.00% | — | — |
| Q2 2025 | Aug 14, 2025 | −$0.10 | −$0.12 | -28.74% | — | — |
| Q1 2025 | May 13, 2025 | −$0.14 | −$0.06 | 57.14% | — | — |
| Q3 2024 | Nov 13, 2024 | −$0.06 | −$0.06 | 0.00% | — | — |
| Q2 2024 | Aug 8, 2024 | −$0.06 | −$0.05 | 16.67% | — | — |
| Q1 2024 | May 9, 2024 | −$0.05 | −$0.06 | -20.00% | — | — |
| Q4 2023 | Feb 15, 2024 | −$0.08 | −$0.08 | 0.00% | — | — |
| Q3 2023 | Nov 9, 2023 | −$0.08 | −$0.01 | 87.50% | — | $1.0M |
| Q2 2023 | Aug 9, 2023 | −$0.07 | −$0.06 | 14.29% | — | — |
| Q1 2023 | May 11, 2023 | −$0.07 | −$0.06 | 14.29% | — | — |
| Q1 2022 | May 12, 2022 | −$0.08 | −$0.07 | 12.50% | — | — |
| Q2 2021 | Aug 12, 2021 | −$0.09 | −$0.09 | -3.81% | — | — |
| Q1 2021 | May 13, 2021 | −$0.08 | $0.00 | 100.00% | — | $4.0M |
| Q3 2020 | Oct 26, 2020 | −$0.12 | −$0.25 | -107.42% | — | — |
| Q1 2020 | Apr 23, 2020 | −$0.08 | −$0.06 | 25.00% | — | — |

## Frequently Asked Questions

### When did MediciNova (MNOV) last report earnings?

MediciNova last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did MNOV beat earnings estimates?

Yes. MediciNova reported EPS of −$0.05 for Q2 2026 against a −$0.06 estimate — a 21.01% beat.

### How much revenue did MNOV report last quarter?

MediciNova reported $459,000.00 in revenue for Q2 2026, against a consensus estimate of $75,000.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).